Atomoxetine Treatment of Attention Deficit/Hyperactivity Disorder Symptoms in 3-6-Year-Old Children with Autism Spectrum Disorder: A Retrospective Cohort Study

• Asıl Yazarlar: Hamza A. Alsayouf (Yazar), Osama Alsarhan (Yazar), Wael Khreisat (Yazar), Azhar Daoud (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: MDPI AG, 2024-01-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Atomoxetine is indicated for the management of attention deficit/hyperactivity disorder (ADHD) in children and adolescents aged 6 to 18 years. Few studies have assessed the safety and tolerability of atomoxetine in younger patients. This retrospective cohort study included 133 children aged 3-6 year...